- Home
- VNDA vs CBAN Comparison
VNDA vs CBAN Comparison
Compare VNDA & CBAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- CBAN
- Stock Information
- Founded
- VNDA 2002
- CBAN 1975
- Country
- VNDA United States
- CBAN United States
- Employees
- VNDA N/A
- CBAN N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- CBAN Major Banks
- Sector
- VNDA Health Care
- CBAN Finance
- Exchange
- VNDA Nasdaq
- CBAN Nasdaq
- Market Cap
- VNDA 282.8M
- CBAN 295.6M
- IPO Year
- VNDA 2006
- CBAN 1998
- Fundamental
- Price
- VNDA $4.88
- CBAN $16.20
- Analyst Decision
- VNDA Strong Buy
- CBAN
- Analyst Count
- VNDA 2
- CBAN 0
- Target Price
- VNDA $16.50
- CBAN N/A
- AVG Volume (30 Days)
- VNDA 652.5K
- CBAN 82.1K
- Earning Date
- VNDA 05-07-2025
- CBAN 04-23-2025
- Dividend Yield
- VNDA N/A
- CBAN 2.81%
- EPS Growth
- VNDA N/A
- CBAN 9.88
- EPS
- VNDA N/A
- CBAN 1.36
- Revenue
- VNDA $198,772,000.00
- CBAN $112,401,000.00
- Revenue This Year
- VNDA $14.36
- CBAN $14.25
- Revenue Next Year
- VNDA $44.53
- CBAN $6.28
- P/E Ratio
- VNDA N/A
- CBAN $11.97
- Revenue Growth
- VNDA 3.18
- CBAN 1.93
- 52 Week Low
- VNDA $3.71
- CBAN $10.33
- 52 Week High
- VNDA $6.75
- CBAN $18.49
- Technical
- Relative Strength Index (RSI)
- VNDA 52.81
- CBAN 48.06
- Support Level
- VNDA $4.84
- CBAN $15.55
- Resistance Level
- VNDA $5.04
- CBAN $16.59
- Average True Range (ATR)
- VNDA 0.22
- CBAN 0.38
- MACD
- VNDA -0.00
- CBAN 0.02
- Stochastic Oscillator
- VNDA 45.61
- CBAN 66.67
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About CBAN Colony Bankcorp Inc.
Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division, and small business specialty lending divisions. It generates maximum revenue from the Banking Division.